ASX - By Stock
|
NZS |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
Cbyrne11
|
6 |
2.4K |
1 |
31/01/23 |
31/01/23 |
ASX - By Stock
|
6
|
2.4K
|
1
|
|
ASX - By Stock
|
M7T |
Re:
Ann: Mach7 Signs Multi-Year $16.7M Customer Contract
|
|
Cbyrne11
|
21 |
9.7K |
1 |
03/01/23 |
03/01/23 |
ASX - By Stock
|
21
|
9.7K
|
1
|
|
ASX - By Stock
|
NZS |
Re:
Sleeping Giant no more, NZS is an emerging growth story... What’s Next?
|
|
Cbyrne11
|
1.5K |
519K |
5 |
07/12/22 |
07/12/22 |
ASX - By Stock
|
1.5K
|
519K
|
5
|
|
ASX - By Stock
|
RGT |
Re:
Ann: Amended June Quarterly Reports (amended App. 4C)
|
|
Cbyrne11
|
4 |
1.3K |
1 |
25/07/22 |
25/07/22 |
ASX - By Stock
|
4
|
1.3K
|
1
|
|
ASX - By Stock
|
NZS |
Re:
Ann: Supply Agreement signed for NZ$793,000 of Dried Ling Maw
|
|
Cbyrne11
|
13 |
5.1K |
8 |
15/06/22 |
15/06/22 |
ASX - By Stock
|
13
|
5.1K
|
8
|
|
ASX - By Stock
|
M7T |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
Cbyrne11
|
25 |
14K |
7 |
29/04/22 |
29/04/22 |
ASX - By Stock
|
25
|
14K
|
7
|
|
ASX - By Stock
|
RGT |
Re:
Ann: MALTA CIMETRA PRODUCTION FACILITY UPDATE
|
|
Cbyrne11
|
22 |
9.0K |
4 |
03/11/21 |
03/11/21 |
ASX - By Stock
|
22
|
9.0K
|
4
|
|
ASX - By Stock
|
M7T |
Re:
Lawsuit
|
|
Cbyrne11
|
8 |
4.6K |
0 |
02/11/21 |
02/11/21 |
ASX - By Stock
|
8
|
4.6K
|
0
|
|
ASX - By Stock
|
NZS |
Re:
Ann: Quarterly Update and Appendix 4C
|
|
Cbyrne11
|
43 |
26K |
10 |
30/10/21 |
30/10/21 |
ASX - By Stock
|
43
|
26K
|
10
|
|
ASX - By Stock
|
NZS |
Re:
Ann: Quarterly Update and Appendix 4C
|
|
Cbyrne11
|
25 |
7.9K |
3 |
03/08/21 |
03/08/21 |
ASX - By Stock
|
25
|
7.9K
|
3
|
|
ASX - By Stock
|
NZS |
Re:
Ann: Quarterly Update and Appendix 4C
|
|
Cbyrne11
|
25 |
7.9K |
4 |
31/07/21 |
31/07/21 |
ASX - By Stock
|
25
|
7.9K
|
4
|
|
ASX - By Stock
|
NZS |
Re:
Ann: Quarterly Update and Appendix 4C
|
|
Cbyrne11
|
25 |
7.9K |
4 |
30/07/21 |
30/07/21 |
ASX - By Stock
|
25
|
7.9K
|
4
|
|
ASX - By Stock
|
RGT |
Re:
Ann: Response to ASX Query Letter
|
|
Cbyrne11
|
17 |
8.1K |
4 |
21/07/21 |
21/07/21 |
ASX - By Stock
|
17
|
8.1K
|
4
|
|
ASX - By Stock
|
RGT |
Re:
Ann: Response to ASX Query Letter
|
|
Cbyrne11
|
17 |
8.1K |
6 |
20/07/21 |
20/07/21 |
ASX - By Stock
|
17
|
8.1K
|
6
|
|
ASX - By Stock
|
M7T |
Re:
Ann: Q4 Quarterly Activities Report
|
|
Cbyrne11
|
36 |
16K |
1 |
20/07/21 |
20/07/21 |
ASX - By Stock
|
36
|
16K
|
1
|
|
ASX - By Stock
|
M7T |
Re:
Ann: Q4 Quarterly Activities Report
|
|
Cbyrne11
|
36 |
16K |
2 |
20/07/21 |
20/07/21 |
ASX - By Stock
|
36
|
16K
|
2
|
|
ASX - By Stock
|
M7T |
Re:
Ann: Mach7 Licenses eUnity to Advocate Aurora Health
|
|
Cbyrne11
|
8 |
3.3K |
1 |
19/07/21 |
19/07/21 |
ASX - By Stock
|
8
|
3.3K
|
1
|
|
ASX - By Stock
|
RGT |
Re:
Ann: MARCH QUARTERLY ACTIVITY AND CASHFLOW REPORT
|
|
Cbyrne11
|
19 |
5.7K |
5 |
27/04/21 |
27/04/21 |
ASX - By Stock
|
19
|
5.7K
|
5
|
|
ASX - By Stock
|
M7T |
Re:
Ann: Appendix 4C - quarterly
|
|
Cbyrne11
|
12 |
3.8K |
5 |
12/04/21 |
12/04/21 |
ASX - By Stock
|
12
|
3.8K
|
5
|
|
ASX - By Stock
|
M7T |
Re:
Ann: Appendix 4C - quarterly
|
|
Cbyrne11
|
12 |
3.8K |
3 |
12/04/21 |
12/04/21 |
ASX - By Stock
|
12
|
3.8K
|
3
|
|
ASX - By Stock
|
M7T |
Re:
Is $1.50 the new base ?
|
|
Cbyrne11
|
103 |
47K |
0 |
29/03/21 |
29/03/21 |
ASX - By Stock
|
103
|
47K
|
0
|
|
ASX - By Stock
|
M7T |
Re:
Is $1.50 the new base ?
|
|
Cbyrne11
|
103 |
47K |
0 |
15/03/21 |
15/03/21 |
ASX - By Stock
|
103
|
47K
|
0
|
|
ASX - By Stock
|
M7T |
Re:
Ann: First Half Year Results Investor Presentation
|
|
Cbyrne11
|
22 |
10K |
0 |
05/03/21 |
05/03/21 |
ASX - By Stock
|
22
|
10K
|
0
|
|
ASX - By Stock
|
M7T |
Re:
Ann: First Half Year Results Investor Presentation
|
|
Cbyrne11
|
22 |
10K |
0 |
05/03/21 |
05/03/21 |
ASX - By Stock
|
22
|
10K
|
0
|
|
ASX - By Stock
|
M7T |
Re:
Ann: Mach7 Announces 1H 2021 Results
|
|
Cbyrne11
|
20 |
8.9K |
1 |
18/02/21 |
18/02/21 |
ASX - By Stock
|
20
|
8.9K
|
1
|
|
ASX - By Stock
|
M7T |
Re:
Ann: Mach7 Announces 1H 2021 Results
|
|
Cbyrne11
|
20 |
8.9K |
2 |
18/02/21 |
18/02/21 |
ASX - By Stock
|
20
|
8.9K
|
2
|
|
Charts
|
M7T |
Re:
Close to breakout
|
|
Cbyrne11
|
428 |
232K |
2 |
09/02/21 |
09/02/21 |
Charts
|
428
|
232K
|
2
|
|
ASX - By Stock
|
NZS |
Re:
Ann: Quarterly Update and Appendix 4C
|
|
Cbyrne11
|
73 |
24K |
15 |
29/01/21 |
29/01/21 |
ASX - By Stock
|
73
|
24K
|
15
|
|
ASX - By Stock
|
RGT |
Re:
Ann: Completion of Unmarketable Parcel Share Sale Facility
|
|
Cbyrne11
|
12 |
5.3K |
4 |
10/12/20 |
10/12/20 |
ASX - By Stock
|
12
|
5.3K
|
4
|
|
ASX - By Stock
|
RGT |
Re:
Ann: Completion of Unmarketable Parcel Share Sale Facility
|
|
Cbyrne11
|
12 |
5.3K |
4 |
10/12/20 |
10/12/20 |
ASX - By Stock
|
12
|
5.3K
|
4
|
|
ASX - By Stock
|
RGT |
Re:
Ann: September Quarterly Activity and Cashflow Report
|
|
Cbyrne11
|
18 |
4.2K |
2 |
28/10/20 |
28/10/20 |
ASX - By Stock
|
18
|
4.2K
|
2
|
|
ASX - By Stock
|
RGT |
Re:
holding balance
|
|
Cbyrne11
|
32 |
10K |
1 |
12/10/20 |
12/10/20 |
ASX - By Stock
|
32
|
10K
|
1
|
|
ASX - By Stock
|
RGT |
Re:
holding balance
|
|
Cbyrne11
|
32 |
10K |
1 |
12/10/20 |
12/10/20 |
ASX - By Stock
|
32
|
10K
|
1
|
|
ASX - By Stock
|
RGT |
Re:
holding balance
|
|
Cbyrne11
|
32 |
10K |
1 |
08/10/20 |
08/10/20 |
ASX - By Stock
|
32
|
10K
|
1
|
|
ASX - By Stock
|
RGT |
Re:
Ann: Unmarketable Parcel Share Sale Facility
|
|
Cbyrne11
|
22 |
8.0K |
2 |
17/09/20 |
17/09/20 |
ASX - By Stock
|
22
|
8.0K
|
2
|
|
ASX - By Stock
|
RGT |
Re:
Ann: Unmarketable Parcel Share Sale Facility
|
|
Cbyrne11
|
22 |
8.0K |
0 |
17/09/20 |
17/09/20 |
ASX - By Stock
|
22
|
8.0K
|
0
|
|
ASX - By Stock
|
RGT |
Re:
Ann: Unmarketable Parcel Share Sale Facility
|
|
Cbyrne11
|
22 |
8.0K |
0 |
17/09/20 |
17/09/20 |
ASX - By Stock
|
22
|
8.0K
|
0
|
|
ASX - By Stock
|
RGT |
Re:
Ann: Appendix 4E and Preliminary Unaudited Financial Report
|
|
Cbyrne11
|
35 |
11K |
0 |
17/09/20 |
17/09/20 |
ASX - By Stock
|
35
|
11K
|
0
|
|
ASX - By Stock
|
RGT |
Re:
Ann: Appendix 4E and Preliminary Unaudited Financial Report
|
|
Cbyrne11
|
35 |
11K |
0 |
16/09/20 |
16/09/20 |
ASX - By Stock
|
35
|
11K
|
0
|
|
ASX - By Stock
|
RGT |
Re:
Ann: Trading Halt
|
|
Cbyrne11
|
45 |
16K |
0 |
16/09/20 |
16/09/20 |
ASX - By Stock
|
45
|
16K
|
0
|
|
ASX - By Stock
|
NZS |
Re:
Ann: Underwritten Share Purchase Plan and Top-Up Placement
|
|
Cbyrne11
|
112 |
35K |
1 |
07/09/20 |
07/09/20 |
ASX - By Stock
|
112
|
35K
|
1
|
|
ASX - By Stock
|
RGT |
Re:
Ann: Appendix 4E and Preliminary Unaudited Financial Report
|
|
Cbyrne11
|
35 |
11K |
0 |
03/09/20 |
03/09/20 |
ASX - By Stock
|
35
|
11K
|
0
|
|
ASX - By Stock
|
M7T |
Re:
Ann: Preliminary Final Report and Audited Financial Statements
|
|
Cbyrne11
|
4 |
1.5K |
5 |
27/08/20 |
27/08/20 |
ASX - By Stock
|
4
|
1.5K
|
5
|
|
ASX - By Stock
|
AS1 |
Re:
Ann: Pause in Trading
|
|
Cbyrne11
|
12 |
3.5K |
0 |
25/08/20 |
25/08/20 |
ASX - By Stock
|
12
|
3.5K
|
0
|
|
ASX - By Stock
|
AS1 |
Re:
Ann: Pause in Trading
|
|
Cbyrne11
|
12 |
3.5K |
1 |
25/08/20 |
25/08/20 |
ASX - By Stock
|
12
|
3.5K
|
1
|
|
ASX - By Stock
|
AS1 |
Re:
Ann: Pause in Trading
|
|
Cbyrne11
|
12 |
3.5K |
0 |
25/08/20 |
25/08/20 |
ASX - By Stock
|
12
|
3.5K
|
0
|
|
ASX - By Stock
|
RGT |
Re:
Ann: COVID-19 Interim Trial Results Meet All Primary Objectives
|
|
Cbyrne11
|
141 |
41K |
2 |
20/08/20 |
20/08/20 |
ASX - By Stock
|
141
|
41K
|
2
|
|
ASX - By Stock
|
RGT |
Re:
Ann: COVID-19 Interim Trial Results Meet All Primary Objectives
|
|
Cbyrne11
|
141 |
41K |
2 |
20/08/20 |
20/08/20 |
ASX - By Stock
|
141
|
41K
|
2
|
|
ASX - By Stock
|
RGT |
Re:
Ann: COVID-19 Interim Trial Results Meet All Primary Objectives
|
|
Cbyrne11
|
141 |
41K |
11 |
20/08/20 |
20/08/20 |
ASX - By Stock
|
141
|
41K
|
11
|
|
ASX - By Stock
|
RGT |
Re:
Ann: UK DISTRIBUTION AGREEMENT SIGNED FOR MGC PHARMA MEDICINES
|
|
Cbyrne11
|
107 |
39K |
3 |
20/08/20 |
20/08/20 |
ASX - By Stock
|
107
|
39K
|
3
|
|